Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Determine Safety and Feasibility of the Stratagen Quantitative Prostate MRI Platform as an Adjunct to Standard of Care MRI When Evaluating for Clinically Significant Prostate Cancer

NCT06985238 is registered in ClinicalTrials.gov with Stratagen Bio, Inc. as lead sponsor.

NCT NCT06985238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06985238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Determine Safety and Feasibility of the Stratagen Quantitative Prostate MRI Platform as an Adjunct to Standard of Care MRI When Evaluating for Clinically Significant Prostate Cancer
Lead sponsor
Stratagen Bio, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 24, 2025
Completion date
May 30, 2027
Enrollment
75 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer